AB-BIOBETTER to pioneer development of new oral formulation of adalimumab for inflammatory bowel diseases; offering patients less invasive, less costly and potentially more potent treatment options Bio-Sourcing
Bio-Thera Solutions and Intract Pharma announced at the end of last month that they had entered into a global collaboration and licensing agreement that gives Bio-Thera access to two.